Literature DB >> 21050116

Variability in the lipooligosaccharide structure and endotoxicity among Bordetella pertussis strains.

Nico Marr1, Alexey Novikov, Adeline M Hajjar, Martine Caroff, Rachel C Fernandez.   

Abstract

Bordetella endotoxins show remarkable structural variability both among each other and in comparison to other gram-negative bacteria. Here we demonstrate that, in contrast to the common Bordetella pertussis laboratory strain and Tohama I derivative BP338, lipooligosaccharide from mouse challenge strain 18-323 is a poor inducer of inflammatory cytokines in human and murine macrophages, is greatly impaired in Toll-like receptor 4-mediated activation of nuclear factor-κB in transfected HEK-293 cells, and functions as a Toll-like receptor 4 antagonist. Comparison of lipid A and lipooligosaccharide structures of B. pertussis strains BP338 and 18-323 revealed that 18-323 (1) lacks the ability to modify its lipid A phosphate groups with glucosamine, (2) is distinct in its acylation at the C3' position of the lipid A diglucosamine backbone, and (3) expresses molecular lipooligosaccharide species that lack a terminal heptose. Our findings have important implications for interpreting previous studies of host defenses to B. pertussis infection in mice and in vitro.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21050116     DOI: 10.1086/657409

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.

Authors:  Nina Maeshima; Tara Evans-Atkinson; Adeline M Hajjar; Rachel C Fernandez
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

2.  Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cells.

Authors:  Jolanda Brummelman; Rosanne E Veerman; Hendrik Jan Hamstra; Anna J M Deuss; Tim J Schuijt; Arjen Sloots; Betsy Kuipers; Cécile A C M van Els; Peter van der Ley; Frits R Mooi; Wanda G H Han; Elena Pinelli
Journal:  Infect Immun       Date:  2014-10-27       Impact factor: 3.441

3.  Structural and biological characteristics of different forms of V. filiformis lipid A: use of MS to highlight structural discrepancies.

Authors:  Aude Breton; Alexey Novikov; Richard Martin; Pierre Tissieres; Martine Caroff
Journal:  J Lipid Res       Date:  2017-01-25       Impact factor: 5.922

4.  Minor modifications to the phosphate groups and the C3' acyl chain length of lipid A in two Bordetella pertussis strains, BP338 and 18-323, independently affect Toll-like receptor 4 protein activation.

Authors:  Nita R Shah; Sami Albitar-Nehme; Emma Kim; Nico Marr; Alexey Novikov; Martine Caroff; Rachel C Fernandez
Journal:  J Biol Chem       Date:  2013-03-06       Impact factor: 5.157

Review 5.  Review of the neutrophil response to Bordetella pertussis infection.

Authors:  Joshua C Eby; Casandra L Hoffman; Laura A Gonyar; Erik L Hewlett
Journal:  Pathog Dis       Date:  2015-10-02       Impact factor: 3.951

6.  Differentially expressed genes in Bordetella pertussis strains belonging to a lineage which recently spread globally.

Authors:  Daan de Gouw; Peter W M Hermans; Hester J Bootsma; Aldert Zomer; Kees Heuvelman; Dimitri A Diavatopoulos; Frits R Mooi
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

7.  Protein evolution of Toll-like receptors 4, 5 and 7 within Galloanserae birds.

Authors:  Michal Vinkler; Hana Bainová; Josef Bryja
Journal:  Genet Sel Evol       Date:  2014-11-12       Impact factor: 4.297

Review 8.  Recognition of lipid A variants by the TLR4-MD-2 receptor complex.

Authors:  Nina Maeshima; Rachel C Fernandez
Journal:  Front Cell Infect Microbiol       Date:  2013-02-12       Impact factor: 5.293

Review 9.  Development of a new trend conjugate vaccine for the prevention of Klebsiella pneumoniae.

Authors:  Tarek A Ahmad; Medhat Haroun; Ahmad A Hussein; El Sayed H El Ashry; Laila H El-Sayed
Journal:  Infect Dis Rep       Date:  2012-07-23

Review 10.  Roads to the development of improved pertussis vaccines paved by immunology.

Authors:  Jolanda Brummelman; Mieszko M Wilk; Wanda G H Han; Cécile A C M van Els; Kingston H G Mills
Journal:  Pathog Dis       Date:  2015-09-06       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.